The IPO gains knew no boundaries, said Cramer. There were successful deals in health care, energy, technology, materials, financials and even in the transportation sector. Among the quarter's only losers were REITs and those with company-specific worries, such as
(GOGO), the in-flight wireless provider that now needs massive injections of capital in order to build out its network.
Cramer said the IPO trend will be continuing in the third quarter, which is why he wants investors to look into the upcoming IPOs of
OncoMed Pharmaceuticals and
Envision Healthcare, along with online coupon purveyors
Retail Me Not, all of which will be coming soon to a market near you.
Pick the Right Dollar Store
Don't be tricked into buying the stock of the wrong dollar store, Cramer cautioned viewers. He said that shares of
(FDO - Get Report) may have popped on earnings, but it's the least of Cramer's favorites in the group.
Cramer said while Family Dollar's earnings may have looked good on the surface, they were merely better than most people had feared. That's not really an achievement, said Cramer, which is why he continues to like rival
(DG - Get Report), which is up 26% for the year and is still worth owning.
Dollar General is expecting same-store sales to increase 4% to 5% this year and the company sees the opportunity for over 10,000 locations across the U.S. That's why the company plans to open a stunning 650 locations this year, while remodeling another 550. Shares of Dollar General trade at just 14.8 times earnings with a 15% growth rate, compared to 16.4 times for Family Dollar, which only has a 12% growth rate.
However, the most exciting stock in the dollar store space remains
(FIVE - Get Report)
, said Cramer, which is a regional to national story that has already delivered a 122% return since its IPO last year. Five Below may trade at 41 times earnings, but with the company growing at a whopping 31% a year that multiple is well deserved.
Cramer said the demand for Five Below shares from institutional investors is far from over, which is why this stock remains on the top of his list.
In the Lightning Round, Cramer was bullish on
Cramer was bearish on
Alpha Natural Resources
Executive Decision: Jeff Stein
In the "Executive Decision" segment, Cramer spoke with Jeff Stein, president and CEO of
, a biotech on the front lines in fighting drug-resistant bacteria. Shares of Trius have already doubled this year.
Stein said there has been a significant change of mindset regarding drug-resistant bacteria. He said one year ago Congress passed the GAIN Act, which stands for Generate Antibiotic Incentives Now. That act has turned the Food and Drug Administration into a terrific partner in helping to get much needed new drugs to market as quickly as possible.
Stein explained that every year over 100,000 patients die in hospitals from infections that simply cannot be treated by current antibiotics. He said the problem is huge, which is why Trius' drugs are aiming to not only combat the problem head on, but also get patients out of the hospital faster so they can avoid exposure in the first place.
When asked about the company's expansion plans, Stein said Trius is partnering with some terrific companies to bring its drugs to market around the globe. He said the focus will be on both development and commercialization going forward.
Cramer said Trius remains a great story, but with a red-hot, low-dollar stock, investors must use limit orders when purchasing shares.
No Huddle Offense
In his "No Huddle Offense" segment, Cramer asked the question: Is the rally in the bank stocks over?
Cramer noted that while interest rates have begun to rise, the banks still lack the pricing power to increase their net interest margins, which is one way they make money. More regulations have also meant banks still need to raise more capital, which means less money is available for lending. Finally, he noted that mortgage loans have taken a momentary decline after last month's interest rate spike, also hampering short-term gains for the banks.
So does that mean the rally is over? Cramer said that the long-term prospects for an economy on the mend continue to favor the banks, which is why he would still be a buyer on weakness.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here:
Follow Scott on Twitter
or get updates on Facebook,